289 related articles for article (PubMed ID: 1846888)
1. Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction.
Takeda K; LaFrance ND; Weisman HF; Wagner HN; Becker LC
J Am Coll Cardiol; 1991 Feb; 17(2):519-26. PubMed ID: 1846888
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m pyrophosphate and indium-111 antimyosin antibody scintigraphy appear to be comparable methods for infarct detection.
Willerson JT; Buja LM
J Am Coll Cardiol; 1991 Feb; 17(2):527-9. PubMed ID: 1846889
[No Abstract] [Full Text] [Related]
3. Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate.
Khaw BA; Strauss HW; Moore R; Fallon JT; Yasuda T; Gold HK; Haber E
J Nucl Med; 1987 Jan; 28(1):76-82. PubMed ID: 3025386
[TBL] [Abstract][Full Text] [Related]
4. Localization of In-111 antimyosin Fab and 99mTc-pyrophosphate in reperfusion myocardial infarction model.
Lee DS; Lee MC; Chung JK; Koh CS; Moon DH
Korean J Intern Med; 1990 Jan; 5(1):15-22. PubMed ID: 2176819
[TBL] [Abstract][Full Text] [Related]
5. Indium-111-antimyosin antibody imaging for detecting different stages of myocardial infarction: comparison with technetium-99m-pyrophosphate imaging.
Tamaki N; Yamada T; Matsumori A; Yoshida A; Fujita T; Ohtani H; Watanabe Y; Yonekura Y; Endo K; Konishi J
J Nucl Med; 1990 Feb; 31(2):136-42. PubMed ID: 2156026
[TBL] [Abstract][Full Text] [Related]
6. Myocardial distribution of indium-111-antimyosin Fab in acute inferior and right ventricular infarction: comparison with technetium-99m-pyrophosphate imaging and histologic examination.
Nakata T; Sakakibara T; Noto T; Shoji T; Tsuda T; Kubota M; Hattori A; Iimura O
J Nucl Med; 1991 May; 32(5):865-7. PubMed ID: 1850785
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of myocardial infarct detection using Tc99m pyrophosphate and In111 DTPA antimyosin (R11D10 Fab).
Cox PH; Schonfeld D; Remme WF; Pillay M; Brons R
Int J Card Imaging; 1987; 2(3):197-8. PubMed ID: 2828484
[TBL] [Abstract][Full Text] [Related]
8. Blood flow-dependent uptake of indium-111 monoclonal antimyosin antibody in canine acute myocardial infarction.
Mody FV; Buxton DB; Araujo LI; Fishbein ME; Selin CE; Schelbert HR; Schwaiger M
J Am Coll Cardiol; 1993 Jan; 21(1):233-9. PubMed ID: 7678020
[TBL] [Abstract][Full Text] [Related]
9. Detection of acute myocardial infarcts by infarct-avid imaging.
Willerson JT
J Nucl Med; 1991 Feb; 32(2):269-71. PubMed ID: 1846912
[No Abstract] [Full Text] [Related]
10. The current role of infarct avid imaging.
Khaw BA
Semin Nucl Med; 1999 Jul; 29(3):259-70. PubMed ID: 10433340
[TBL] [Abstract][Full Text] [Related]
11. [Gammagraphic evaluation of myocardial necrosis using antimyosin monoclonal antibodies].
Sampere JJ; Torrededía J; Ruiz García J; Martín Navajas JA; Puentes C; López Ruiz JM; Moreno Galán S; Correa Vílchez C; Pedraza V
Rev Esp Cardiol; 1988; 41 Suppl 2():61-9. PubMed ID: 2853429
[No Abstract] [Full Text] [Related]
12. [Scintigraphy of "hot foci" in myocardial infarction while using technetium 99m labelled pyrophosphate and antimyosin antibodies labelled with radioactive indium 111].
Wasilewski J; Juszczyk J; Pasyk S
Pol Tyg Lek; 1991 May 6-20; 46(19-21):386-8. PubMed ID: 1845680
[TBL] [Abstract][Full Text] [Related]
13. Detection of myocardial necrosis and inflammation by nuclear cardiac imaging.
Taillefer R
Cardiol Clin; 1994 May; 12(2):289-302. PubMed ID: 8033178
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of acute myocardial infarction by indium-111 antimyosin antibodies and correlation with the traditional techniques for the evaluation of extent and localization.
Volpini M; Giubbini R; Gei P; Cuccia C; Franzoni P; Riva S; Terzi A; Metra M; Bestagno M; Visioli O
Am J Cardiol; 1989 Jan; 63(1):7-13. PubMed ID: 2535772
[TBL] [Abstract][Full Text] [Related]
15. Myocardial distribution of indium-111-antimyosin Fab and technetium-99m-sestamibi in experimental nontransmural infarction.
Morguet AJ; Munz DL; Klein HH; Pich S; Conrady A; Nebendahl K; Kreuzer H; Emrich D
J Nucl Med; 1992 Feb; 33(2):223-8. PubMed ID: 1531070
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of myocardial infarct size before and after reperfusion: dual-tracer imaging with radiolabeled antimyosin antibody.
Narula J; Nicol PD; Southern JF; Pieri P; O'Donnell SM; Guererro JL; Nossiff ND; Newell JB; Strauss HW; Khaw BA
J Nucl Med; 1994 Jun; 35(6):1076-85. PubMed ID: 8195873
[TBL] [Abstract][Full Text] [Related]
17. Measurement of myocardial infarction fraction using single photon emission computed tomography.
Wolfe CL; Lewis SE; Corbett JR; Parkey RW; Buja LM; Willerson JT
J Am Coll Cardiol; 1985 Jul; 6(1):145-51. PubMed ID: 2989347
[TBL] [Abstract][Full Text] [Related]
18. Effect of reperfusion on 111In-antimyosin monoclonal antibody uptake by salvaged and necrotic myocardium in the dog.
Merhi Y; Arsenault A; Carrier M; Latour JG
Cardiovasc Res; 1993 Aug; 27(8):1504-9. PubMed ID: 8221805
[TBL] [Abstract][Full Text] [Related]
19. [Scintigraphy using 111In-labeled antimyosin F(ab)2 monoclonal antibodies and 99m Tc-pyrophosphate in rhabdomyolysis].
Krause T; Schümichen C; Hohenloser S; Kasper W; Meinertz T
Nuklearmedizin; 1988 Feb; 27(1):38-9. PubMed ID: 2835754
[No Abstract] [Full Text] [Related]
20. A comparison of infarct identification with technetium-99m pyrophosphate and staining with triphenyl tetrazolium chloride.
Izquierdo C; Devous MD; Nicod P; Buja LM; Parkey RW; Bonte FJ; Willerson JT; Lewis SE
J Nucl Med; 1983 Jun; 24(6):492-7. PubMed ID: 6304264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
